90 related articles for article (PubMed ID: 11996001)
21. Design, synthesis, and antifolate activity of new analogues of piritrexim and other diaminopyrimidine dihydrofolate reductase inhibitors with omega-carboxyalkoxy or omega-carboxy-1-alkynyl substitution in the side chain.
Chan DC; Fu H; Forsch RA; Queener SF; Rosowsky A
J Med Chem; 2005 Jun; 48(13):4420-31. PubMed ID: 15974594
[TBL] [Abstract][Full Text] [Related]
22. Structure of the Q67H mutant of R67 dihydrofolate reductase-NADP+ complex reveals a novel cofactor binding mode.
Divya N; Grifith E; Narayana N
Protein Sci; 2007 Jun; 16(6):1063-8. PubMed ID: 17473013
[TBL] [Abstract][Full Text] [Related]
23. Analysis of hydride transfer and cofactor fluorescence decay in mutants of dihydrofolate reductase: possible evidence for participation of enzyme molecular motions in catalysis.
Farnum MF; Magde D; Howell EE; Hirai JT; Warren MS; Grimsley JK; Kraut J
Biochemistry; 1991 Dec; 30(49):11567-79. PubMed ID: 1747376
[TBL] [Abstract][Full Text] [Related]
24. Atomic structures of human dihydrofolate reductase complexed with NADPH and two lipophilic antifolates at 1.09 a and 1.05 a resolution.
Klon AE; Héroux A; Ross LJ; Pathak V; Johnson CA; Piper JR; Borhani DW
J Mol Biol; 2002 Jul; 320(3):677-93. PubMed ID: 12096917
[TBL] [Abstract][Full Text] [Related]
25. Dihydrofolate reductase from Kaposi's sarcoma-associated herpesvirus.
Cinquina CC; Grogan E; Sun R; Lin SF; Beardsley GP; Miller G
Virology; 2000 Mar; 268(1):201-17. PubMed ID: 10683342
[TBL] [Abstract][Full Text] [Related]
26. New insights into DHFR interactions: analysis of Pneumocystis carinii and mouse DHFR complexes with NADPH and two highly potent 5-(omega-carboxy(alkyloxy) trimethoprim derivatives reveals conformational correlations with activity and novel parallel ring stacking interactions.
Cody V; Pace J; Chisum K; Rosowsky A
Proteins; 2006 Dec; 65(4):959-69. PubMed ID: 17019704
[TBL] [Abstract][Full Text] [Related]
27. Molecular modelling of trimethoprim complexes of human wild-type and mutant dihydrofolate reductases: identification of two subsets of binding residues in the antifolate binding site.
Pan R; Bowen D; Southerland WM
Biopharm Drug Dispos; 1999 Oct; 20(7):335-40. PubMed ID: 10760841
[TBL] [Abstract][Full Text] [Related]
28. Comparison of two independent crystal structures of human dihydrofolate reductase ternary complexes reduced with nicotinamide adenine dinucleotide phosphate and the very tight-binding inhibitor PT523.
Cody V; Galitsky N; Luft JR; Pangborn W; Rosowsky A; Blakley RL
Biochemistry; 1997 Nov; 36(45):13897-903. PubMed ID: 9374868
[TBL] [Abstract][Full Text] [Related]
29. Further studies on 2,4-diamino-5-(2',5'-disubstituted benzyl)pyrimidines as potent and selective inhibitors of dihydrofolate reductases from three major opportunistic pathogens of AIDS.
Rosowsky A; Forsch RA; Queener SF
J Med Chem; 2003 Apr; 46(9):1726-36. PubMed ID: 12699390
[TBL] [Abstract][Full Text] [Related]
30. Mechanism inspired development of rationally designed dihydrofolate reductase inhibitors as anticancer agents.
Singh P; Kaur M; Sachdeva S
J Med Chem; 2012 Jul; 55(14):6381-90. PubMed ID: 22734697
[TBL] [Abstract][Full Text] [Related]
31. Analysis of three crystal structure determinations of a 5-methyl-6-N-methylanilino pyridopyrimidine antifolate complex with human dihydrofolate reductase.
Cody V; Luft JR; Pangborn W; Gangjee A
Acta Crystallogr D Biol Crystallogr; 2003 Sep; 59(Pt 9):1603-9. PubMed ID: 12925791
[TBL] [Abstract][Full Text] [Related]
32. Contributions of tryptophan 24 and glutamate 30 to binding long-lived water molecules in the ternary complex of human dihydrofolate reductase with methotrexate and NADPH studied by site-directed mutagenesis and nuclear magnetic resonance spectroscopy.
Meiering EM; Li H; Delcamp TJ; Freisheim JH; Wagner G
J Mol Biol; 1995 Mar; 247(2):309-25. PubMed ID: 7707377
[TBL] [Abstract][Full Text] [Related]
33. Evidence for a functional role of the dynamics of glycine-121 of Escherichia coli dihydrofolate reductase obtained from kinetic analysis of a site-directed mutant.
Cameron CE; Benkovic SJ
Biochemistry; 1997 Dec; 36(50):15792-800. PubMed ID: 9398309
[TBL] [Abstract][Full Text] [Related]
34. Increasing methotrexate resistance by combination of active-site mutations in human dihydrofolate reductase.
Volpato JP; Fossati E; Pelletier JN
J Mol Biol; 2007 Oct; 373(3):599-611. PubMed ID: 17868689
[TBL] [Abstract][Full Text] [Related]
35. Calorimetric studies of ligand binding in R67 dihydrofolate reductase.
Jackson M; Chopra S; Smiley RD; Maynord PO; Rosowsky A; London RE; Levy L; Kalman TI; Howell EE
Biochemistry; 2005 Sep; 44(37):12420-33. PubMed ID: 16156655
[TBL] [Abstract][Full Text] [Related]
36. A single amino acid substitution in Staphylococcus aureus dihydrofolate reductase determines trimethoprim resistance.
Dale GE; Broger C; D'Arcy A; Hartman PG; DeHoogt R; Jolidon S; Kompis I; Labhardt AM; Langen H; Locher H; Page MG; Stüber D; Then RL; Wipf B; Oefner C
J Mol Biol; 1997 Feb; 266(1):23-30. PubMed ID: 9054967
[TBL] [Abstract][Full Text] [Related]
37. Analysis of quinazoline and pyrido[2,3-d]pyrimidine N9-C10 reversed-bridge antifolates in complex with NADP+ and Pneumocystis carinii dihydrofolate reductase.
Cody V; Galitsky N; Luft JR; Pangborn W; Queener SF; Gangjee A
Acta Crystallogr D Biol Crystallogr; 2002 Sep; 58(Pt 9):1393-9. PubMed ID: 12198294
[TBL] [Abstract][Full Text] [Related]
38. Conformational analysis of human dihydrofolate reductase inhibitor complexes: crystal structure determination of wild type and F31 mutant binary and ternary inhibitor complexes.
Cody V; Wojtczak A; Kalman TI; Friesheim JH; Blakley RL
Adv Exp Med Biol; 1993; 338():481-6. PubMed ID: 8304163
[TBL] [Abstract][Full Text] [Related]
39. Effect of cofactor binding and loop conformation on side chain methyl dynamics in dihydrofolate reductase.
Schnell JR; Dyson HJ; Wright PE
Biochemistry; 2004 Jan; 43(2):374-83. PubMed ID: 14717591
[TBL] [Abstract][Full Text] [Related]
40. Structural analysis of Pneumocystis carinii dihydrofolate reductase complexed with NADPH and 2,4-diamino-6-[2-(5-carboxypent-1-yn-1-yl)-5-methoxybenzyl]-5-methylpyrido[2,3-d]pyrimidine.
Cody V; Pace J; Stewart E
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Apr; 68(Pt 4):418-23. PubMed ID: 22505410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
